FDA Inspection 1196232 — Reproductive Medicine Associates Of Philadelphia, P.C.
The FDA completed an inspection of Reproductive Medicine Associates Of Philadelphia, P.C. on Jan 24, 2023 in Langhorne, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 24, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Langhorne, PA (United States)